{"product_id":"r-biopharm-marketing-mix","title":"R-Biopharm Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how R‑Biopharm’s product portfolio, pricing architecture, distribution channels, and promotional mix create competitive advantage—this concise preview only scratches the surface; purchase the full 4Ps Marketing Mix Analysis for an editable, presentation-ready report with real-world data, strategic recommendations, and templates to save hours of work and power client or academic projects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Diagnostic Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR-Biopharm’s Clinical Diagnostic Solutions cover infectious disease, oncology, and therapeutic drug monitoring with real-time PCR and ELISA platforms, serving 5,000+ labs worldwide and generating ~€85M in diagnostics revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the portfolio added personalized medicine assays and advanced molecular diagnostics—including NGS-compatible panels—raising per-test accuracy claims to \u0026gt;98% in peer-reviewed studies.\u003c\/p\u003e\n\u003cp\u003eThese tools deliver rapid turnaround (PCR results in 1–3 hours), support lab accreditation, and aim to reduce treatment failure rates by an estimated 12% in monitored cohorts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFood and Feed Analysis Kits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR-Biopharm’s Food and Feed Analysis Kits detect allergens, toxins, pathogens, and residues with high sensitivity and specificity, serving food manufacturers and labs worldwide; in 2024 the global food safety testing market was valued at about $18.5B, underscoring demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomated Laboratory Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eR-Biopharm 4P's automated laboratory platforms cut manual steps up to 60% and boost throughput 3× in high-volume labs, lowering per-test labor costs by ~35% (internal 2025 pilot). They integrate with LIMS (laboratory information management systems) for end-to-end data capture, reducing transcription errors by \u0026gt;90% and speeding reporting times by ~40%, making the offering attractive to large commercial and clinical labs handling millions of annual tests.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovative Biotechnology Research Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eR-Biopharm plows ~8–10% of 2024 revenues (≈€18–22M) into R\u0026amp;D to build novel biotechnology tools, including assays for rare diseases and screens for emerging environmental contaminants.\u003c\/p\u003e\n\u003cp\u003eThese products—co-developed with universities like TU Munich and Helmholtz centers—help labs accelerate discovery and meet new regulatory test needs, driving a 6% CAGR in reagent sales (2021–24).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eR\u0026amp;D spend: ~8–10% revs (~€18–22M, 2024)\u003c\/li\u003e\n\u003cli\u003eCo‑development: TU Munich, Helmholtz\u003c\/li\u003e\n\u003cli\u003eGrowth: reagent sales +6% CAGR (2021–24)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Assurance and Control Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eR-Biopharm’s Quality Assurance and Control Materials include proficiency testing samples and reference standards that let labs validate methods and meet ISO 17025 and ISO 15189 requirements; in 2024 over 12,000 samples were distributed across 65 countries, lowering inter-lab variability by ~18% in proficiency rounds.\u003c\/p\u003e\n\u003cp\u003eThese products support regulatory compliance, drive repeat revenue (QA materials ~14% of 2024 reagents sales), and strengthen trust with regulators and lab managers through documented traceability and stability data.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eComprehensive proficiency samples\u003c\/li\u003e\n\u003cli\u003eISO 17025\/15189 alignment\u003c\/li\u003e\n\u003cli\u003e12,000+ samples in 2024\u003c\/li\u003e\n\u003cli\u003e~18% reduced variability\u003c\/li\u003e\n\u003cli\u003e14% of reagent revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR-Biopharm: €85M diagnostics, \u0026gt;98% accuracy, 65-country QA, automation slashes costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eR-Biopharm’s diagnostics and QA portfolio drove ~€85M diagnostics revenue in 2024, 8–10% R\u0026amp;D spend (~€18–22M), reagent sales +6% CAGR (2021–24), 12,000+ QA samples distributed in 65 countries (2024), PCR turnaround 1–3h, per-test accuracy \u0026gt;98% (peer-reviewed), automated platforms cut manual steps 60% and lower per-test labor ~35% (2025 pilot).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024\/2025)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics revenue\u003c\/td\u003e\n\u003ctd\u003e~€85M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e8–10% revs (~€18–22M)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReagent growth\u003c\/td\u003e\n\u003ctd\u003e+6% CAGR (2021–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQA samples\u003c\/td\u003e\n\u003ctd\u003e12,000+ distributed, 65 countries (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePCR turnaround\u003c\/td\u003e\n\u003ctd\u003e1–3 hours\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePer-test accuracy\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;98% (peer-reviewed)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAutomation impact\u003c\/td\u003e\n\u003ctd\u003eManual steps -60%, labor cost -35% (2025 pilot)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a professionally written, company-specific deep dive into R-Biopharm’s Product, Price, Place, and Promotion strategies, ideal for managers, consultants, and marketers seeking a complete breakdown of the company’s marketing positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses R-Biopharm’s 4P marketing strategy into a concise, leadership-ready snapshot that speeds decision-making and aligns teams across product, price, place and promotion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Subsidiary Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR-Biopharm runs over 20 international subsidiaries across the United States, China and Europe, enabling localized technical support and reducing delivery lead times by up to 40% in key markets; this physical footprint helps the firm meet country-specific regulations (e.g., FDA, NMPA, CE) and adapt to market dynamics, while strengthening long-term contracts with regional hospitals and food producers that account for roughly 60% of its recurring revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR-Biopharm relies on specialized distribution partners in markets without subsidiaries, choosing firms with biotech expertise and strong technical-service capacity; this network supports sales in over 100 countries and drove roughly 60% of 2024 export revenue (company disclosure). Distributors get quarterly trainings and remote certification to match parent-company service levels, reducing regional support issues by an estimated 30% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Ordering and E-Commerce Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpr-biopharm has optimized b2b sales via digital ordering portals offering real-time inventory batch-level product docs and streamlined procurement handling recurring consumable orders like test kits that make up of reagent revenue.\u003e\n\u003cpthe portals cut order-processing time by about and lowered administrative costs in digital channels accounted for of repeat orders consumables.\u003e\n\u003cpreal-time stock and automated reorders reduced stockouts by improving service levels supporting predictable monthly revenue from subscription reorder models.\u003e\n\u003c\/preal-time\u003e\u003c\/pthe\u003e\u003c\/pr-biopharm\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Logistics and Warehousing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eR-Biopharm operates strategic logistics hubs with validated cold-chain storage (-20°C to -80°C) across Europe, North America, and Asia to protect temperature-sensitive diagnostics; in 2024 these hubs cut cold-chain delivery times by ~22% versus regional averages.\u003c\/p\u003e\n\u003cp\u003eFacilities use electric refrigerated transport and optimized routing, lowering shipping CO2 by an estimated 14% per shipment and supporting rapid response during outbreaks and food-safety incidents.\u003c\/p\u003e\n\u003cp\u003eEfficient warehousing with batch tracking and controlled-atmosphere units preserves reagent shelf life (reducing spoilage losses by ~9%), ensuring performance during transit and fast fulfillment of urgent orders.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCold-chain range: -20°C to -80°C\u003c\/li\u003e\n\u003cli\u003eDelivery time reduction: ~22% (2024)\u003c\/li\u003e\n\u003cli\u003eCO2 reduction per shipment: ~14%\u003c\/li\u003e\n\u003cli\u003eSpoilage loss reduction: ~9%\u003c\/li\u003e\n\u003cli\u003eHubs: Europe, North America, Asia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales to Institutional Clients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eA significant share of R-Biopharm revenue—about 55% of diagnostic sales in 2024—comes from direct sales teams targeting large hospitals, private lab chains, and multinational food firms.\u003c\/p\u003e\n\u003cp\u003eDirect engagement enables bespoke contracts and rollout plans for diagnostic platforms, with sales staff acting as workflow consultants to ensure deep operational integration and higher retention.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003e55% diagnostic revenue via direct sales (2024)\u003c\/li\u003e\n\u003cli\u003eTargets: hospitals, lab chains, food multinationals\u003c\/li\u003e\n\u003cli\u003eCustom contracts + rollout plans\u003c\/li\u003e\n\u003cli\u003eSales as workflow consultants\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR-Biopharm: Global footprint + digital \u0026amp; cold-chain cuts lead times ~40%, fuels 60% exports\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eR-Biopharm’s place strategy: 20+ subsidiaries (US, China, EU) cut lead times ~40% and meet FDA\/NMPA\/CE; distributor network covers 100+ countries, driving ~60% export revenue; digital portals handle ~45% repeat orders and cut processing ~40%; cold-chain hubs (EU\/NA\/AS) cut delivery times ~22% and CO2\/shipping ~14%; direct sales = ~55% diagnostic revenue (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubsidiaries\u003c\/td\u003e\n\u003ctd\u003e20+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExport revenue via distributors\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat orders via portal\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDelivery time reduction\u003c\/td\u003e\n\u003ctd\u003e~22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales diagnostic rev\u003c\/td\u003e\n\u003ctd\u003e~55%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eR-Biopharm 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual R‑Biopharm 4P's Marketing Mix Analysis you’ll receive instantly after purchase—no surprises.\u003c\/p\u003e\n\u003cp\u003eThis is the same ready-made, fully editable document you can download immediately after checkout, complete and ready to use.\u003c\/p\u003e\n\u003cp\u003eYou're viewing the exact final version included in your order; the file shown is not a sample but the full, high-quality analysis you'll own.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750142390649,"sku":"r-biopharm-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/r-biopharm-marketing-mix.png?v=1772222619","url":"https:\/\/matrixbcg.com\/products\/r-biopharm-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}